A cluster randomised controlled trial of a MedicineInsight educational quality improvement program to improve the diagnosis and treatment of chronic hepatitis C in Australian general practice - the EQUIP-HEPC trial

Not Applicable

Completed

• Conditions: Chronic hepatitis C (CHC); Infection - Other infectious diseases; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12619000508178
• Lead Sponsor: PS MedicineWise (Not-for-profit)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-28
• Study Completion: 2020-06-19
• Last Update Posted: 15 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 201

Inclusion Criteria

General Practice sites:
1.Participates in the MedicineInsight Program and meets MedicineInsight data quality requirements
2.Located in a geographical area serviced by one of the CSS field force delivering the intervention
3.Use of Medical Director or Best Practice for EHR management
4.Has 5 or more patients with possible or confirmed CHC* who visited the practice at least once in the 2 years prior to randomisation
*As part of a previous project related to hepatitis C, we have developed a set of search algorithms that scan the data in MedicineInsight for terms that indicate confirmed or possible CHC. These algorithms and terms are outlined in detail by Chidwick et al (2018) . The algorithms search for a patient’s most recent docle and pyefinch codes as well as free text expressions pertaining to hepatitis C in clinical system records that describe reason for encounter, reason for prescription, or diagnosis. Additional criteria are applied to confirm CHC in patients whose most recent status is indeterminate, including prescriptions, tests, and complications related to CHC.

Exclusion Criteria

Practices that participated in the 2017 NPS MedicineWise educational program on Hepatitis C will be excluded.

Practices that withdraw their consent to participate in this study, or in the MedicineInsight program, during the period of analysis will not be included in this study. Practice-level withdrawals are rare in MedicineInsight. Data for patients who opt-out from the program will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified